نام کتاب:
Diagnostic Pathology: Molecular Oncology, 3rd edition (ePub+Converted PDF)
نويسنده/نويسندگان: By Mohammad A. Vasef MD, Aaron Auerbach MD MPH
نوع فايل: (ePub+Converted PDF)
سال انتشار: 2024
تعداد صفحات : 1048
ناشر : Publisher : Elsevier; 3rd edition (January 2, 2024)
شابک :9780443112201
نسخه چاپی تمام رنگی ، با کیفیت بالا ،جلد هارد
*بهترین کیفیت افست را از ما بخواهید*
شماره تمای برای هماهنگی 09371686566
و همچنین واتس اپ و تلگرام ما
To buy in dollars, if you have PayPal, send a message to our Telegram
+989371686566
By Mohammad A. Vasef MD, Aaron Auerbach MD MPH
This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Providing a clear understanding of molecular pathology as it relates to the transformation and pathogenesis of cancer in an era of personalized medicine, it incorporates the most recent scientific and technical knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, the third edition of Diagnostic Pathology: Molecular Oncology is a visually stunning, one-stop resource for every practicing pathologist, hematopathologist, molecular pathologist, oncologist, or pathologist in training as an ideal day-to-day reference or as a reliable learning resource.
Molecular oncology is a rapidly evolving field with tremendous amounts of information that is new since the 2e published in March 2019. There is new molecular genetic data linked to either new targeted therapies or that serves as diagnostic or prognostic indicators. The 3e will include 8-10 new chapters and substantial updates and rewrites to existing contents to make sure ongoing edits and revisions to the upcoming WHO Classification of Hematopoietic Tumors are included in the 3e. The authors provide guidance on selecting the right test(s) at the right time for the right patient and comparisons of molecular testing methods (i.e., FSH testing vs. cytogenetics) are included. The market lacks a definitive source of all the recent changes, and DP3 Molecular Oncology will provide a comprehensive information source.